Web Desc
Immunological Mechanisms of Vaccination
Organizer(s): Adrian V.S. Hill, Dan H. Barouch, John T. Harty and Tania H. Watts
Date: December 13 - 18, 2012
Location: Fairmont Château Laurier, Ottawa, ON, Canada
Part of the Keystone Symposia Global Health Series, supported by the Bill & Melinda Gates Foundation
For important information on the coronavirus, please click here
Summary of Meeting:
Vaccines are remarkably successful in reducing morbidity and mortality from infectious diseases in both developed and developing countries. However, globally, mortality from infectious disease still exceeds 10 million deaths annually, reflecting a need for new, more effective and more deployable vaccination approaches. As many of the relatively easy vaccines have already been made, vaccinology is now tackling more difficult diseases, often caused by complex and genetically variable pathogens. A better understanding of the immunological mechanisms underpinning existing and novel vaccines is therefore required. Fortunately, research efforts to uncover new molecular and cellular techniques offer exceptional opportunities for improved vaccine design. A better understanding of the immunology of vaccination will be of value in evidence-based design of new vaccines against major global causes of mortality such as HIV, malaria and tuberculosis, and against emerging infections such as swine influenza and dengue. Advances in immunology, genomics and systems biology are beginning to offer a deeper understanding of the molecular and cellular mechanisms of host immunity, and the pivotal role played by the innate immune system in shaping the adaptive immune response. This is providing new opportunities to identify new signatures of vaccine immunogenicity and protective efficacy, which should facilitate vaccine development and guide improved vaccine design. The Keystone Symposia meeting on Immunological Mechanisms of Vaccination will bring together an interdisciplinary group of scientists in vaccinology, immunology and pathogen biology, to address recent advances in these fields and their potential for accelerating vaccine design and development.
Global Health Travel Award Deadline: July 18 2012
Scholarship Deadline: August 13 2012
Discounted Abstract Deadline: August 13 2012
Abstract Deadline: September 13 2012
Discounted Registration Deadline: October 11 2012
Keystone Symposia thanks our Sponsor(s) for generously supporting this meeting:
Bill & Melinda Gates Foundation
We gratefully acknowledge additional support for this conference from:
Biogen Idec
We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:

Novartis Vaccines and Diagnostics
We gratefully acknowledge the generous grant for this conference provided by:

National Institute of Allergy and Infectious Diseases (NIAID)
Grant No. 1R13AI102519-01
The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations

Program

Thursday, December 13 | 12:00PM - 7:30PM
Arrival and Registration
Room: Main Lobby


Thursday, December 13 | 4:00PM - 5:30PM
Welcome and Keynote Address (Joint with Grand Challenges Mee
ting)
Room: Canada Hall 1, Ottawa Convention Centre

Speaker 1 of 3
* Christopher L. Karp, Bill & Melinda Gates Foundation, USA

Thursday, December 13 | 4:00PM - 5:30PM
Welcome and Keynote Address (Joint with Grand Challenges Mee
ting)
Room: Canada Hall 1, Ottawa Convention Centre

Speaker 2 of 3
Chris Wilson, Bill & Melinda Gates Foundation, USA
Translating Immunology into Vaccinology

Thursday, December 13 | 4:00PM - 5:30PM
Welcome and Keynote Address (Joint with Grand Challenges Mee
ting)
Room: Canada Hall 1, Ottawa Convention Centre

Speaker 3 of 3
Bruce A. Beutler, University of Texas Southwestern Medical Center, USA
Genetics and Innate Immunity

Thursday, December 13 | 5:30PM - 8:00PM
Social Hour with Lite Bites
Room: Trillium Ballroom, Ottawa Convention Centre


Friday, December 14 | 7:30AM - 9:00AM
Breakfast
Room: Adam/Drawing Rooms


Friday, December 14 | 9:00AM - 12:15PM
Innate Sensing of Pathogens and Vaccines
Room: Ballroom

Speaker 1 of 7
* Julie Magarian Blander, Weill Cornell Medicine, Cornell University, USA

Friday, December 14 | 9:00AM - 12:15PM
Innate Sensing of Pathogens and Vaccines
Room: Ballroom

Speaker 2 of 7
Stephanie C. Eisenbarth, Yale University, USA
NLR Regulation of Dendritic Cell Priming during Immunization

Friday, December 14 | 9:00AM - 12:15PM
Innate Sensing of Pathogens and Vaccines
Room: Ballroom

Speaker 3 of 7
Yan Shi, University of Calgary, Canada
Immune Activation by Force

Friday, December 14 | 9:00AM - 12:15PM
Innate Sensing of Pathogens and Vaccines
Room: Ballroom

Speaker 4 of 7
Dana Philpott, University of Toronto, Canada
Nod Proteins: Regulators of Inflammation and Autophagy

Friday, December 14 | 9:00AM - 12:15PM
Innate Sensing of Pathogens and Vaccines
Room: Ballroom

Speaker 5 of 7
William R. Heath, University of Melbourne, Australia
Dendritic Cell Receptors and T Cell Induction

Friday, December 14 | 9:00AM - 12:15PM
Innate Sensing of Pathogens and Vaccines
Room: Ballroom

Speaker 6 of 7
Nicolas Chevrier, Harvard University, USA
Short Talk: System-Level Analysis of the Toll-Like Receptor Network Delineates Viral and Inflammatory Sensing Circuits

Friday, December 14 | 9:00AM - 12:15PM
Innate Sensing of Pathogens and Vaccines
Room: Ballroom

Speaker 7 of 7
Taryn L. Osmond, Malaghan Institute of Medical Research, New Zealand
Short Talk: Splenic CD8alpha+Langerin+ Dendritic Cells: Firing up the Immune Environment for CD8+ T Cell Responses

Friday, December 14 | 10:20AM - 10:40AM
Coffee Break
Room: Adam/Drawing Rooms


Friday, December 14 | 12:15PM - 1:00PM
Poster Setup
Room: Adam/Drawing Rooms


Friday, December 14 | 12:15PM - 12:15PM
On Own for Lunch and Recreation


Friday, December 14 | 1:00PM - 10:00PM
Poster Viewing
Room: Adam/Drawing Rooms


Friday, December 14 | 2:00PM - 4:00PM
Workshop 1: Novel Adjuvants
Room: Ballroom

Speaker 1 of 9
* Katrina D. Gee, Queen's University, Canada

Friday, December 14 | 2:00PM - 4:00PM
Workshop 1: Novel Adjuvants
Room: Ballroom

Speaker 2 of 9
* Sam Basta, Queen's University, Canada

Friday, December 14 | 2:00PM - 4:00PM
Workshop 1: Novel Adjuvants
Room: Ballroom

Speaker 3 of 9
Frank Wegmann, Janssen, Netherlands
Polyethyleneimine is a Potent Mucosal Adjuvant for Glycoproteins with Innate and Adaptive Immune Activating Properties

Friday, December 14 | 2:00PM - 4:00PM
Workshop 1: Novel Adjuvants
Room: Ballroom

Speaker 4 of 9
Sang Mu Shim, Korea Research Institute of Bioscience and Biotechnology (KRIBB), South Korea
Poly gamma Glutamic Acid-Chitosan Nanogel Dramatically Enhance the Efficacy of Pandemic H1N1 Influenza Vaccine

Friday, December 14 | 2:00PM - 4:00PM
Workshop 1: Novel Adjuvants
Room: Ballroom

Speaker 5 of 9
Thomas W. Dubensky, Jr., Tempest Therapeutics, USA
Development of Cyclic Dinucleotides (CDNs) as STING-Targeted Molecular Adjuvants

Friday, December 14 | 2:00PM - 4:00PM
Workshop 1: Novel Adjuvants
Room: Ballroom

Speaker 6 of 9
Karen Smith Korsholm, Statens Serum Institut, Denmark
The Effect of the Immunostimulating Glycolipid MMG in Cationic Liposomal Vaccine Adjuvants

Friday, December 14 | 2:00PM - 4:00PM
Workshop 1: Novel Adjuvants
Room: Ballroom

Speaker 7 of 9
Silvia Vendetti, Istituto Superiore di Sanità, Italy
Achieving Mucosal and Systemic Immunity by Exploiting Vitamin A Metabolites as Vaccine Co-Adjuvants

Friday, December 14 | 2:00PM - 4:00PM
Workshop 1: Novel Adjuvants
Room: Ballroom

Speaker 8 of 9
Esteban Celis, Moffitt Cancer Center, USA
BiVax: A Peptide/Poly-IC Subunit Vaccine that Mimics an Acute Infection Elicits Vast and Effective Anti-Tumor CD8 T Cell Responses

Friday, December 14 | 2:00PM - 4:00PM
Workshop 1: Novel Adjuvants
Room: Ballroom

Speaker 9 of 9
Maria L. Knudsen, Fred Hutchinson Cancer Research Center, USA
Alphavirus Replicons Encoding the TLR5 Ligand Flagellin is a Potent Adjuvant for IgG Response

Friday, December 14 | 4:00PM - 4:30PM
Coffee Available
Room: Adam/Drawing Rooms


Friday, December 14 | 4:30PM - 7:15PM
Augmenting Immune Responses to Vaccines
Room: Ballroom

Speaker 1 of 6
* Dan H. Barouch, Beth Israel Deaconess Medical Center, USA

Friday, December 14 | 4:30PM - 7:15PM
Augmenting Immune Responses to Vaccines
Room: Ballroom

Speaker 2 of 6
Robert A. Seder, NIAID, National Institutes of Health, USA
Differential Effects of Innate Immunity and Antigen Load on CD8 T Cell Immunity Following Viral Vaccination

Friday, December 14 | 4:30PM - 7:15PM
Augmenting Immune Responses to Vaccines
Room: Ballroom

Speaker 3 of 6
Tania H. Watts, University of Toronto, Canada
CD137L (4-1BBL) as an Immune Stimulant in Acute and Chronic Viral Infections

Friday, December 14 | 4:30PM - 7:15PM
Augmenting Immune Responses to Vaccines
Room: Ballroom

Speaker 4 of 6
Rafick Sekaly, Case Western Reserve University, USA
Systems Biology Approaches Show the Impact of Ethnic Groups on Innate and Adaptive Characteristics that Correlate with Protective Immune Responses to the Yellow Fever Vaccine

Friday, December 14 | 4:30PM - 7:15PM
Augmenting Immune Responses to Vaccines
Room: Ballroom

Speaker 5 of 6
Daniel D. Pinschewer, University of Geneva, Switzerland
LCMV-Based Vaccine Vectors: Viral Immunobiology Teaches Vaccinology

Friday, December 14 | 4:30PM - 7:15PM
Augmenting Immune Responses to Vaccines
Room: Ballroom

Speaker 6 of 6
Nicolas Cuburu, NIH, National Cancer Institute, USA
Short Talk: Prime/Boost Genital Immunization with Human Papillomaviral Vectors Preferentially Induces CD103+CD8+ Tissue Resident Memory Cells in the Mouse Female Genital Tract

Friday, December 14 | 7:15PM - 8:15PM
Social Hour with Lite Bites
Room: Adam/Drawing Rooms


Friday, December 14 | 7:30PM - 10:00PM
Poster Session 1
Room: Adam/Drawing Rooms


Saturday, December 15 | 7:30AM - 9:00AM
Breakfast
Room: Adam/Drawing Rooms


Saturday, December 15 | 8:00AM - 9:00AM
Poster Setup
Room: Adam/Drawing Rooms


Saturday, December 15 | 9:00AM - 5:00PM
Poster Viewing
Room: Adam/Drawing Rooms


Saturday, December 15 | 9:00AM - 12:15PM
T Cell Memory to Vaccines
Room: Ballroom

Speaker 1 of 8
* Nathalie Labrecque, Maisonneuve-Rosemont Hospital Research Centre, Canada

Saturday, December 15 | 9:00AM - 12:15PM
T Cell Memory to Vaccines
Room: Ballroom

Speaker 2 of 8
* Susan M. Kaech, The Salk Institute, USA

Saturday, December 15 | 9:00AM - 12:15PM
T Cell Memory to Vaccines
Room: Ballroom

Speaker 3 of 8
Ton N. Schumacher, Netherlands Cancer Institute, Netherlands
Technologies for Tracking T Cell Responses

Saturday, December 15 | 9:00AM - 12:15PM
T Cell Memory to Vaccines
Room: Ballroom

Speaker 4 of 8
John T. Harty, University of Iowa, USA
Alternative Strategies for Generating Protective Numbers of Memory CD8 T Cells by Prime-Boost Immunization

Saturday, December 15 | 9:00AM - 12:15PM
T Cell Memory to Vaccines
Room: Ballroom

Speaker 5 of 8
Ross M. Kedl, University of Colorado Denver, USA
Short Talk: Antigen Persistence after Subunit Vaccination Correlates with the Generation and Maintenance of Protective Cellular Immunity

Saturday, December 15 | 9:00AM - 12:15PM
T Cell Memory to Vaccines
Room: Ballroom

Speaker 6 of 8
Marc K. Jenkins, University of Minnesota Medical School, USA
Origins of CD4+ Memory T Cells

Saturday, December 15 | 9:00AM - 12:15PM
T Cell Memory to Vaccines
Room: Ballroom

Speaker 7 of 8
David B. Masopust, University of Minnesota, USA
CD8 T Cell Memory Induced by Heterologous Prime-Boost Vaccination

Saturday, December 15 | 9:00AM - 12:15PM
T Cell Memory to Vaccines
Room: Ballroom

Speaker 8 of 8
Cara Skon, Genentech, Inc., USA
Short Talk: Transcriptional Downregulation of S1PR1 is Required for Establishment of Resident Memory CD8 T Cells

Saturday, December 15 | 10:20AM - 10:40AM
Coffee Break
Room: Adam/Drawing Rooms


Saturday, December 15 | 12:15PM - 1:15PM
Lunch
Room: Adam/Drawing Rooms


Saturday, December 15 | 1:00PM - 3:30PM
Poster Session 2
Room: Adam/Drawing Rooms


Saturday, December 15 | 3:30PM - 4:00PM
Coffee Available
Room: Adam/Drawing Rooms


Saturday, December 15 | 4:00PM - 6:00PM
B Cell Memory to Vaccines
Room: Ballroom

Speaker 1 of 6
* Jamie K. Scott, Simon Fraser University, Canada

Saturday, December 15 | 4:00PM - 6:00PM
B Cell Memory to Vaccines
Room: Ballroom

Speaker 2 of 6
* Richard A. Kroczek, Robert Koch-Institute, Germany

Saturday, December 15 | 4:00PM - 6:00PM
B Cell Memory to Vaccines
Room: Ballroom

Speaker 3 of 6
Bonnie B. Blomberg, University of Miami School of Medicine, USA
Biomaker and Molecular Mechanisms for Human B cell and Antibody Responsiveness to Vaccines

Saturday, December 15 | 4:00PM - 6:00PM
B Cell Memory to Vaccines
Room: Ballroom

Speaker 4 of 6
Michel C. Nussenzweig, HHMI/Rockefeller University, USA
Human Antibody Responses to HIV

Saturday, December 15 | 4:00PM - 6:00PM
B Cell Memory to Vaccines
Room: Ballroom

Speaker 5 of 6
Shane Crotty, La Jolla Institute for Immunology, USA
Tfh Cells: Providing T Cell Help for B Cell Responses

Saturday, December 15 | 4:00PM - 6:00PM
B Cell Memory to Vaccines
Room: Ballroom

Speaker 6 of 6
Peter Sage, Harvard Medical School, USA
Short Talk: PD-1 Controls Lymph Node and Blood T Follicular Regulatory Cells

Saturday, December 15 | 5:00PM - 5:00PM
On Own for Dinner


Sunday, December 16 | 7:30AM - 9:00AM
Breakfast
Room: Adam/Drawing Rooms


Sunday, December 16 | 9:00AM - 11:45AM
Understanding Signatures of Vaccine Protective Efficacy
Room: Ballroom

Speaker 1 of 7
* Bonnie B. Blomberg, University of Miami School of Medicine, USA

Sunday, December 16 | 9:00AM - 11:45AM
Understanding Signatures of Vaccine Protective Efficacy
Room: Ballroom

Speaker 2 of 7
* Vladimir Badovinac, University of Iowa, USA

Sunday, December 16 | 9:00AM - 11:45AM
Understanding Signatures of Vaccine Protective Efficacy
Room: Ballroom

Speaker 3 of 7
Bali Pulendran, Stanford University School of Medicine, USA
Systems Vaccinology: Enabling Rational Vaccine Design with Systems Biology

Sunday, December 16 | 9:00AM - 11:45AM
Understanding Signatures of Vaccine Protective Efficacy
Room: Ballroom

Speaker 4 of 7
Ennio De Gregorio, GlaxoSmithKline Vaccines, Italy
Immune Profiling of Vaccine Adjuvants

Sunday, December 16 | 9:00AM - 11:45AM
Understanding Signatures of Vaccine Protective Efficacy
Room: Ballroom

Speaker 5 of 7
Susan M. Kaech, The Salk Institute, USA
Regulation or Antiviral Immunity by PGE-2 During Chronic Viral Infection

Sunday, December 16 | 9:00AM - 11:45AM
Understanding Signatures of Vaccine Protective Efficacy
Room: Ballroom

Speaker 6 of 7
Willem A. Hanekom, Bill & Melinda Gates Foundation, USA
Human Gene Expression Signatures of Risk of Tuberculosis Disease

Sunday, December 16 | 9:00AM - 11:45AM
Understanding Signatures of Vaccine Protective Efficacy
Room: Ballroom

Speaker 7 of 7
Magali Matsumiya, University of Oxford, UK
Short Talk: Predicting the Immune Response to MVA85A

Sunday, December 16 | 10:20AM - 10:40AM
Coffee Break
Room: Adam/Drawing Rooms


Sunday, December 16 | 11:45AM - 1:00PM
Poster Setup
Room: Adam/Drawing Rooms


Sunday, December 16 | 11:45AM - 11:45AM
On Own for Lunch and Recreation


Sunday, December 16 | 1:00PM - 10:00PM
Poster Viewing
Room: Adam/Drawing Rooms


Sunday, December 16 | 2:30PM - 4:30PM
Workshop 2: Vaccine Delivery
Room: Ballroom

Speaker 1 of 9
* Adrian V. S. Hill, Jenner Institute, University of Oxford, UK

Sunday, December 16 | 2:30PM - 4:30PM
Workshop 2: Vaccine Delivery
Room: Ballroom

Speaker 2 of 9
Peter Lauer, Aduro BioTech, Inc., USA
Recombinase-Induced Intracellular Death (Lm-RIID): A Novel, Safe, and Potent L. Monocytogenes Vaccine Platform

Sunday, December 16 | 2:30PM - 4:30PM
Workshop 2: Vaccine Delivery
Room: Ballroom

Speaker 3 of 9
Ana Carolina dos Reis Albuquerque Cajaraville, Instituto de Tecnologia em Imunobiologicos Bio-Manguinhos, Brazil
Characterization of a Malaria Vaccine Candidate Based in the Yellow Fever 17D Virus Vector

Sunday, December 16 | 2:30PM - 4:30PM
Workshop 2: Vaccine Delivery
Room: Ballroom

Speaker 4 of 9
Matthew D. J. Dicks, University of Oxford, UK
Why Are Some Adenovirus Vaccine Vectors More Immunogenic Than Others?

Sunday, December 16 | 2:30PM - 4:30PM
Workshop 2: Vaccine Delivery
Room: Ballroom

Speaker 5 of 9
* Allan Randrup Thomsen, University of Copenhagen, Denmark
Generation of Transgene-Specific CD8 T Cells by Immunization with Adenoviral Vectors Is Markedly Augmented by Co-Expression of Transgene and IL-2 in the Same Vector

Sunday, December 16 | 2:30PM - 4:30PM
Workshop 2: Vaccine Delivery
Room: Ballroom

Speaker 6 of 9
Torben Knuschke, University of Duisburg-Essen, Germany
Biodegradable Calcium Phosphate Nanoparticles: A New Conjugated Vaccine Approach for Prophylactic and Therapeutic Anti-Viral Treatment

Sunday, December 16 | 2:30PM - 4:30PM
Workshop 2: Vaccine Delivery
Room: Ballroom

Speaker 7 of 9
Masaru Kanekiyo, NIAID, National Institutes of Health, USA
A Self-Assembling Influenza Nanoparticle Vaccine Elicits Broad and Potent Neutralizing Antibodies

Sunday, December 16 | 2:30PM - 4:30PM
Workshop 2: Vaccine Delivery
Room: Ballroom

Speaker 8 of 9
Even Fossum, Institute of Immunology, Norway
Vaccines Designed to Specifically Target Cross-Presenting DCs

Sunday, December 16 | 2:30PM - 4:30PM
Workshop 2: Vaccine Delivery
Room: Ballroom

Speaker 9 of 9
Shaomin Tian, University of North Carolina at Chapel Hill, USA
Rational Design of PRINT Nano-Vaccines

Sunday, December 16 | 4:30PM - 5:00PM
Coffee Available
Room: Adam/Drawing Rooms


Sunday, December 16 | 5:00PM - 7:00PM
Translating Immunity to Vaccines
Room: Ballroom

Speaker 1 of 6
* Tania H. Watts, University of Toronto, Canada

Sunday, December 16 | 5:00PM - 7:00PM
Translating Immunity to Vaccines
Room: Ballroom

Speaker 2 of 6
Dan H. Barouch, Beth Israel Deaconess Medical Center, USA
Novel HIV Vaccine Strategies

Sunday, December 16 | 5:00PM - 7:00PM
Translating Immunity to Vaccines
Room: Ballroom

Speaker 3 of 6
Helen McShane, Jenner Institute, UK
Clinical Development of TB Vaccines

Sunday, December 16 | 5:00PM - 7:00PM
Translating Immunity to Vaccines
Room: Ballroom

Speaker 4 of 6
Daniela Weiskopf, La Jolla Institute for Immunology, USA
Short Talk: Comprehensive Analysis of Dengue Virus-Specific Responses Supports an HLA-Linked Protective Role for CD8+ T Cells, Rather Than a Pathogenic Role Linked to Original Antigenic Sin

Sunday, December 16 | 5:00PM - 7:00PM
Translating Immunity to Vaccines
Room: Ballroom

Speaker 5 of 6
Ma Luo, University of Manitoba, Canada
Short Talk: Antibody and T Cell Response to the Protease Cleavage Sites Correlated with Protection Against Higher Dose of SIVmac239 Challenge and Disease Progression in Cynomolgus Macaques

Sunday, December 16 | 5:00PM - 7:00PM
Translating Immunity to Vaccines
Room: Ballroom

Speaker 6 of 6
Bram Slütter, University of Iowa, USA
Short Talk: CXCR3+ Memory CD8+ T Cells Localize to the Respiratory Tract and Provide Superior Protection Against Influenza A Virus

Sunday, December 16 | 7:00PM - 8:00PM
Social Hour with Lite Bites
Room: Adam/Drawing Rooms


Sunday, December 16 | 7:30PM - 10:00PM
Poster Session 3
Room: Adam/Drawing Rooms


Monday, December 17 | 7:30AM - 9:00AM
Breakfast
Room: Adam/Drawing Rooms


Monday, December 17 | 9:00AM - 12:15PM
Immunity and Vaccines Against Global Threats I
Room: Ballroom

Speaker 1 of 8
* John T. Harty, University of Iowa, USA

Monday, December 17 | 9:00AM - 12:15PM
Immunity and Vaccines Against Global Threats I
Room: Ballroom

Speaker 2 of 8
* Helen McShane, Jenner Institute, UK

Monday, December 17 | 9:00AM - 12:15PM
Immunity and Vaccines Against Global Threats I
Room: Ballroom

Speaker 3 of 8
Adrian V. S. Hill, Jenner Institute, University of Oxford, UK
Generating Unnatural Immunity

Monday, December 17 | 9:00AM - 12:15PM
Immunity and Vaccines Against Global Threats I
Room: Ballroom

Speaker 4 of 8
Rafi Ahmed, Emory University School of Medicine, USA
Human B Cell Response to Influenza Virus

Monday, December 17 | 9:00AM - 12:15PM
Immunity and Vaccines Against Global Threats I
Room: Ballroom

Speaker 5 of 8
Dennis L. Kasper, Harvard Medical School, USA
Rethinking Glycocojugate Vaccines: A Knowledge-Based Approach to Vaccine Design

Monday, December 17 | 9:00AM - 12:15PM
Immunity and Vaccines Against Global Threats I
Room: Ballroom

Speaker 6 of 8
Claire A. Jones, University of Oxford, UK
Short Talk: Quantification of Antibody Secreting Cell Responses in a Human Model of Salmonella typhi Infection

Monday, December 17 | 9:00AM - 12:15PM
Immunity and Vaccines Against Global Threats I
Room: Ballroom

Speaker 7 of 8
Mark Y. Sangster, University of Rochester, USA
Short Talk: The B Cell Response to an Inactivated Pandemic H1N1 Influenza Vaccine in Cohorts Differing by Age and Immune Status

Monday, December 17 | 9:00AM - 12:15PM
Immunity and Vaccines Against Global Threats I
Room: Ballroom

Speaker 8 of 8
David Furman, Buck Institute for Research on Aging, USA
Short Talk: Robust Correlates of an Immune Response to Influenza Vaccination in Young and Old Adults

Monday, December 17 | 10:20AM - 10:40AM
Coffee Break
Room: Adam/Drawing Rooms


Monday, December 17 | 12:15PM - 12:15PM
On Own for Lunch and Recreation


Monday, December 17 | 4:30PM - 5:00PM
Coffee Available
Room: Adam/Drawing Rooms


Monday, December 17 | 5:00PM - 7:00PM
Immunity and Vaccines Against Global Threats II
Room: Ballroom

Speaker 1 of 6
* Adrian V. S. Hill, Jenner Institute, University of Oxford, UK

Monday, December 17 | 5:00PM - 7:00PM
Immunity and Vaccines Against Global Threats II
Room: Ballroom

Speaker 2 of 6
* Alessandro Sette, La Jolla Institute for Immunology, USA

Monday, December 17 | 5:00PM - 7:00PM
Immunity and Vaccines Against Global Threats II
Room: Ballroom

Speaker 3 of 6
Dany De Grave, Sanofi Pasteur, USA
The Sanofi Pasteur Tetravalent Dengue Vaccine: An Update

Monday, December 17 | 5:00PM - 7:00PM
Immunity and Vaccines Against Global Threats II
Room: Ballroom

Speaker 4 of 6
Louis J. Picker, Oregon Health & Science University, USA
Unique Immunobiology and Efficacy of SIV Protein-Expressing Cytomegalovirus (CMV) Vectors

Monday, December 17 | 5:00PM - 7:00PM
Immunity and Vaccines Against Global Threats II
Room: Ballroom

Speaker 5 of 6
Jerald C. Sadoff, Crucell Vaccine Institute, Janssen Pharmaceutical Companies of Johnson & Johnson, Netherlands
Vaccine Vectors for HIV and Other Global Threats

Monday, December 17 | 5:00PM - 7:00PM
Immunity and Vaccines Against Global Threats II
Room: Ballroom

Speaker 6 of 6
David M. Lewinsohn, Oregon Health & Science University, USA
Short Talk: Lessons from a Human Phase I Trial: Vaccination with the Mtb Vaccine AERAS-402 (BCG Prime / Adenoviral Boost) Induces High Frequency, Antigen-Specific CD8 T Cells That Do Not Necessarily Recognize the Mtb-Infected Cell

Monday, December 17 | 7:00PM - 8:00PM
Social Hour with Lite Bites
Room: Adam/Drawing Rooms


Monday, December 17 | 8:00PM - 11:00PM
Entertainment
Room: Adam Room


Monday, December 17 | 8:00PM - 11:00PM
Cash Bar
Room: Adam Room


Tuesday, December 18 | 10:23AM - 10:23AM
Departure


*Session Chair
†Invited, not yet responded.